BTIG analyst Thomas Shrader initiates coverage on Serina Therapeutics (AMEX:SER) with a Buy ratin

Gannet BioChem, a leading life sciences manufacturing company, today announced a development partner

HUNTSVILLE, Ala., June 30, 2026 (GLOBE NEWSWIRE) -- Gannet BioChem , a leading life sciences manufac

CAMBRIDGE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leadi

https://www.sec.gov/Archives/edgar/data/1708599/000149315226025007/forms-3.htm

SER-252 Phase 1b Registrational Clinical Study: Following dosing of the first patient in February 20

Serina Therapeutics (AMEX:SER) reported quarterly losses of $(0.58) per share which missed the analy

Serina Therapeutics (AMEX:SER) reported quarterly losses of $(0.31) per share which beat the analyst

(Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the s

US stocks down, Dow falls 300+ points, S&P 500 drops 0.93%, Nasdaq falls 1.25%. Energy shares up

Five Below Inc (FIVE) shares rose 7.2% in pre-market trading after reporting better-than-expected Q4

Serina Therapeutics Inc. surged 39.45% in after-hours trading Wednesday following a $15 million priv

- First tranche of $15 million expected to close on March 20, 2026; second tranche of up to $15 mill

- Blinded evaluation of safety and tolerability data by the Safety Monitoring Committee from Cohort

META: 10% | Meta Platforms shares are trading higher after the company reported better-than-expected

Serina Therapeutics shares jumped nearly 35% after the FDA cleared its IND application for SER-252,

Serina Therapeutics, Inc. ("Serina" or the "Company") (NYSE:SER), a clinical-stage b

Serina Therapeutics, Inc. ("Serina" or the "Company") (NYSE:SER), a clinical-stage b